Albert P. L. Stroucken - 05 Apr 2022 Form 4 Insider Report for BAXTER INTERNATIONAL INC (BAX)

Role: Director
Signature: /s/ Matthew Rice, as attorney in-fact for Albert P. L. Stroucken
Issuer symbol: BAX
Transactions as of: 05 Apr 2022
Net transactions value: -$186,942
Form type: 4
Filing time: 07 Apr 2022, 16:07:30 UTC
Next filing: 05 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BAX	Common Stock, $1 par value	Options Exercise	$118,670	+4,020	+12%	$29.52	38,147	05 Apr 2022	Direct	F1
transaction	BAX	Common Stock, $1 par value	Sale	$212,507	-2,805	-7.4%	$75.76	35,342	05 Apr 2022	Direct	F1, F2
transaction	BAX	Common Stock, $1 par value	Sale	$93,105	-1,215	-3.4%	$76.63	34,127	05 Apr 2022	Direct	F1, F3
holding	BAX	Common Stock, $1 par value						696	05 Apr 2022	By Family Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BAX	Stock Option (Right to Buy)	Options Exercise	$0	-4,020	-100%	$0.000000^*	0	05 Apr 2022	Common Stock, $1 par value	4,020	$29.52	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Transaction effected pursuant to a Rule 10b-1 trading plan entered into by Mr. Stroucken on November 4, 2021 with respect to certain vested stock options previously granted by Baxter International Inc. to Mr. Stroucken which were scheduled to expire on May 8, 2022.
F2	Price reflects weighted average sales price. Range of prices for transactions are $75.32 through $76.30. Full information regarding the number of shares sold at each separate price will be provided by Baxter International Inc. upon request.
F3	Price reflects weighted average sales price. Range of prices for transactions are $76.33 through $76.76. Full information regarding the number of shares sold at each separate price will be provided by Baxter International Inc. upon request.